Artificial Intelligence for Screening of Multiple Corneal Diseases
Application of Deep Learning for Screening Multiple Corneal Diseases
1 other identifier
observational
3,000
1 country
1
Brief Summary
This study developed a deep learning algorithm based on anterior segment images and prospectively validated its ability to identify corneal diseases.The effectiveness and accuracy of this algorithm was evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2021
CompletedFirst Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2024
CompletedNovember 4, 2024
October 1, 2024
1 year
January 8, 2024
October 31, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Area under curve
We used the receiver operating characteristic (ROC) curve and area under curve to examine the ability of this artificial intelligence algorism recognition and classification of corneal diseases.
1 week
Sensitivity and specificity
We used sensitivity and specificity to examine the ability of this artificial intelligence algorism recognition and classification of corneal diseases.
1 week
Study Arms (1)
Cornea diseases diagnosed by artificial intelligence algorithm
Interventions
An artificial intelligence algorithm was applied to diagnose cornea diseases from slit-lamp images.
Eligibility Criteria
The study population is derived from an anonymous database that contains health examination results of the general population.
You may qualify if:
- The quality of slit-lamp images should clinical acceptable.
- More than 90% of the slit-lamp image area including three main regions (sclera, pupil, and lens) are easy to read and discriminate.
You may not qualify if:
- )Insufficient information for diagnosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tiajin Eye Hospital
Tianjin, Tianjin Municipality, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yan Wang, Prof
Tianjin Eye Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 18, 2024
Study Start
December 6, 2020
Primary Completion
December 6, 2021
Study Completion
December 6, 2024
Last Updated
November 4, 2024
Record last verified: 2024-10